248 related articles for article (PubMed ID: 34533900)
21. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
[No Abstract] [Full Text] [Related]
22. Association of Endoscopic Sphincterotomy or Papillary Balloon Dilatation and Biliary Cancer: A Population-Based Cohort Study.
Peng YC; Lin CL; Hsu WY; Chow WK; Lee SW; Yeh HZ; Chang CS; Kao CH
Medicine (Baltimore); 2015 Jun; 94(23):e926. PubMed ID: 26061315
[TBL] [Abstract][Full Text] [Related]
23. Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis.
Saffioti F; Roccarina D; Vesterhus M; Hov JR; Rosenberg W; Pinzani M; Pereira SP; Boberg KM; Thorburn D
Eur J Clin Invest; 2019 May; 49(5):e13088. PubMed ID: 30762236
[TBL] [Abstract][Full Text] [Related]
24. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis.
Newsome JR; Venkatramani R; Heczey A; Danysh HE; Fishman DS; Miloh T
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):e12-e18. PubMed ID: 28937543
[TBL] [Abstract][Full Text] [Related]
25. Cholangiocarcinoma Prognosis Varies over Time Depending on Tumor Site and Pathology.
Kaneko R; Sato Y; Kobayashi Y
J Gastrointestin Liver Dis; 2018 Mar; 27(1):59-66. PubMed ID: 29557416
[TBL] [Abstract][Full Text] [Related]
26. Cholangiocarcinoma in Germany: Epidemiologic trends and impact of misclassification.
Walter D; Ferstl P; Waidmann O; Trojan J; Hartmann S; Schnitzbauer AA; Zeuzem S; Kraywinkel K
Liver Int; 2019 Feb; 39(2):316-323. PubMed ID: 30176117
[TBL] [Abstract][Full Text] [Related]
27. Survival and risk of cholangiocarcinoma in patients with primary sclerosing cholangitis. A population-based study.
Kornfeld D; Ekbom A; Ihre T
Scand J Gastroenterol; 1997 Oct; 32(10):1042-5. PubMed ID: 9361178
[TBL] [Abstract][Full Text] [Related]
28. Tumour stage and overall survival in patients with intrahepatic cholangiocarcinoma and primary sclerosing cholangitis - a retrospective cohort study.
Schramm C; Sapuk A; Hoyer D; Radünz S; Schmidt H
Z Gastroenterol; 2024 Jan; 62(1):37-42. PubMed ID: 38195106
[TBL] [Abstract][Full Text] [Related]
29. Cholangiocarcinoma Trends, Incidence, and Relative Survival in Khon Kaen, Thailand From 1989 Through 2013: A Population-Based Cancer Registry Study.
Kamsa-Ard S; Luvira V; Suwanrungruang K; Kamsa-Ard S; Luvira V; Santong C; Srisuk T; Pugkhem A; Bhudhisawasdi V; Pairojkul C
J Epidemiol; 2019 May; 29(5):197-204. PubMed ID: 30078813
[TBL] [Abstract][Full Text] [Related]
30. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma--current treatment options.
Friman S
Scand J Surg; 2011; 100(1):30-4. PubMed ID: 21491796
[TBL] [Abstract][Full Text] [Related]
32. Cholangiocarcinoma: Epidemiology and risk factors.
Khan SA; Tavolari S; Brandi G
Liver Int; 2019 May; 39 Suppl 1():19-31. PubMed ID: 30851228
[TBL] [Abstract][Full Text] [Related]
33. Cholangiocarcinoma miscoding in hepatobiliary centres.
Selvadurai S; Mann K; Mithra S; Bridgewater J; Malik H; Khan SA
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):635-639. PubMed ID: 33032867
[TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
[TBL] [Abstract][Full Text] [Related]
35. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
36. Incidence and prognosis of cholangiocarcinoma in Danish patients with and without inflammatory bowel disease: a national cohort study, 1978-2003.
Erichsen R; Jepsen P; Vilstrup H; Ekbom A; Sørensen HT
Eur J Epidemiol; 2009; 24(9):513-20. PubMed ID: 19557525
[TBL] [Abstract][Full Text] [Related]
37. Distinct immune surveillance in primary biliary cholangitis and primary sclerosing cholangitis is linked with discrete cholangiocarcinoma risk.
Nanjundappa RH; Christen U; Umeshappa CS
Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37555943
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study.
Guerra I; Bujanda L; Castro J; Merino O; Tosca J; Camps B; Gutiérrez A; Gordillo Ábalos J; de Castro L; Iborra M; Carbajo AY; Taxonera C; Rodríguez-Lago I; Mesonero F; de Francisco R; Gómez-Gómez GJ; Chaparro M; Tardillo CA; Rivero M; Algaba A; Martín Arranz E; Cañete F; Vicente R; Sicilia B; Antolín B; Prieto V; Márquez L; Benítez JM; Camo P; Piqueras M; Gargallo CJ; Hinojosa E; Huguet JM; Pérez Calle JL; Van Domselaar M; Rodriguez C; Calvet X; Muñoz-Villafranca C; García-Sepulcre MF; Munoz-Garrido P; Fernández-Clotet A; Gómez Irwin L; Hernández S; Guardiola J; Sempere L; González Muñoza C; Hernández V; Beltrán B; Barrio J; Alba C; Moraleja I; López-Sanromán A; Riestra S; Martínez Montiel P; Garre A; Arranz L; García MJ; Martín Arranz MD; Corsino P; Arias L; Fernández-Salazar L; Fernández-Pordomingo A; Andreu M; Iglesias E; Ber Y; Mena R; Arroyo Villarino MT; Mora M; Ruiz L; López-Serrano P; Blazquez I; Villoria A; Fernández M; Bermejo F; Banales JM; Domènech E; Gisbert JP;
J Crohns Colitis; 2019 Dec; 13(12):1492-1500. PubMed ID: 31063540
[TBL] [Abstract][Full Text] [Related]
39. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
40. Improvement of serum alkaline phosphatase to <1.5 upper limit of normal predicts better outcome and reduced risk of cholangiocarcinoma in primary sclerosing cholangitis.
Al Mamari S; Djordjevic J; Halliday JS; Chapman RW
J Hepatol; 2013 Feb; 58(2):329-34. PubMed ID: 23085647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]